Modulation of FGF pathway signaling and vascular differentiation using designed oligomeric assemblies

利用设计的寡聚体组装体调控FGF通路信号传导和血管分化

阅读:1
作者:Natasha I Edman ,Ashish Phal ,Rachel L Redler ,Thomas Schlichthaerle ,Sanjay R Srivatsan ,Devon Duron Ehnes ,Ali Etemadi ,Seong J An ,Andrew Favor ,Zhe Li ,Florian Praetorius ,Max Gordon ,Thomas Vincent ,Silvia Marchiano ,Leslie Blakely ,Chuwei Lin ,Wei Yang ,Brian Coventry ,Derrick R Hicks ,Longxing Cao ,Neville Bethel ,Piper Heine ,Analisa Murray ,Stacey Gerben ,Lauren Carter ,Marcos Miranda ,Babak Negahdari ,Sangwon Lee ,Cole Trapnell ,Ying Zheng ,Charles E Murry ,Devin K Schweppe ,Benjamin S Freedman ,Lance Stewart ,Damian C Ekiert ,Joseph Schlessinger ,Jay Shendure ,Gira Bhabha ,Hannele Ruohola-Baker ,David Baker

Abstract

Many growth factors and cytokines signal by binding to the extracellular domains of their receptors and driving association and transphosphorylation of the receptor intracellular tyrosine kinase domains, initiating downstream signaling cascades. To enable systematic exploration of how receptor valency and geometry affect signaling outcomes, we designed cyclic homo-oligomers with up to 8 subunits using repeat protein building blocks that can be modularly extended. By incorporating a de novo-designed fibroblast growth factor receptor (FGFR)-binding module into these scaffolds, we generated a series of synthetic signaling ligands that exhibit potent valency- and geometry-dependent Ca2+ release and mitogen-activated protein kinase (MAPK) pathway activation. The high specificity of the designed agonists reveals distinct roles for two FGFR splice variants in driving arterial endothelium and perivascular cell fates during early vascular development. Our designed modular assemblies should be broadly useful for unraveling the complexities of signaling in key developmental transitions and for developing future therapeutic applications.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。